{"id":126761,"date":"2021-08-26T14:22:41","date_gmt":"2021-08-26T21:22:41","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2021\/08\/estimates-of-americans-with-long-covid-19-per-state"},"modified":"2021-08-26T14:22:41","modified_gmt":"2021-08-26T21:22:41","slug":"estimates-of-americans-with-long-covid-19-per-state","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2021\/08\/estimates-of-americans-with-long-covid-19-per-state","title":{"rendered":"Estimates of Americans with long COVID-19, per state"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/estimates-of-americans-with-long-covid-19-per-state.jpg\"><\/a><\/p>\n<p>About 11.1 million Americans are living with long COVID-19, according to <a href=\"https:\/\/pascdashboard.aapmr.org\/\">new estimates<\/a> from The American Academy of Physical Medicine and Rehabilitation.<\/p>\n<p>Long COVID-19, or persistent symptoms up to six months after being cleared of the illness, affects around 30 percent of individuals who had COVID-19, according to two recent publications from the <em>Journal of the American Medical Association<\/em>. Symptoms of long COVID-19 are varied and may include neurological challenges, cognitive problems, shortness of breath, fatigue, pain and mobility issues.<\/p>\n<p>The AAPM&amp;R has developed a dashboard estimating long COVID-19 infections. The model assumes that 30 percent of people who recover from acute COVID-19 develop long COVID-19, but users can adjust estimates based on higher or lower percentages. U.S. case data is pulled from Baltimore-based Johns Hopkins University <a href=\"https:\/\/coronavirus.jhu.edu\/\">COVID-19 data<\/a>. U.S. census data uses2019estimates.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>About 11.1 million Americans are living with long COVID-19, according to new estimates from The American Academy of Physical Medicine and Rehabilitation. Long COVID-19, or persistent symptoms up to six months after being cleared of the illness, affects around 30 percent of individuals who had COVID-19, according to two recent publications from the Journal of [\u2026]<\/p>\n","protected":false},"author":621,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,47],"tags":[],"class_list":["post-126761","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-neuroscience"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/126761","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/621"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=126761"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/126761\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=126761"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=126761"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=126761"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}